×
About 263 results

ALLMedicine™ Brain Neoplasms Center

Research & Reviews  101 results

Is Mini Beam Ready for Human Trials? Results of Randomized Study of Treating De-Novo Br...
https://doi.org/10.1667/RADE-21-00093.1
Radiation Research; Kundapur V, Mayer M et. al.

May 11th, 2022 - The main challenge in treating malignant brain neoplasms lies in eradicating the tumor while minimizing treatment-related damage. Conventional radiation treatments are associated with considerable side effects. Synchrotron generated micro-beam rad...

Revisiting the use of proton magnetic resonance spectroscopy in distinguishing between ...
https://doi.org/10.1177/19714009221083145
The Neuroradiology Journal; Farche MK, Fachinetti NO et. al.

Apr 22nd, 2022 - Conventional magnetic resonance images (MRI) has limitations in distinguishing primary from secondary brain tumors. Proton magnetic resonance spectroscopy (1H-MRS) allows evaluation of the concentration of metabolites in a brain lesion and, hence,...

Intraventricular Meningiomas: Clinical-Pathological and Genetic Features of a Monocentr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775267
Current Oncology (Toronto, Ont.); Ammendola S, Simbolo M et. al.

Jan 21st, 2022 - Intraventricular meningiomas (IVMs) are rare (0.5-5%) and usually low-grade (90% grade I) brain neoplasms. Their recurrence rate is lower than that of extra-axial meningiomas, but their surgical resection can be burdened with life-threatening comp...

Clinical Significance of Delirium With Catatonic Signs in Patients With Neurological Di...
https://doi.org/10.1176/appi.neuropsych.18120364
The Journal of Neuropsychiatry and Clinical Neurosciences; Ramirez-Bermudez J, Medina-Gutierrez A et. al.

Jan 19th, 2022 - According to DSM-5, catatonia and delirium are mutually exclusive clinical syndromes. The investigators explored the co-occurrence of delirium and catatonia (i.e., catatonic delirium) and the clinical significance of this syndrome with a sample of...

see more →

Clinicaltrials.gov  2 results

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
https://clinicaltrials.gov/ct2/show/NCT00004688

Mar 25th, 2015 - PROTOCOL OUTLINE: Patients receive mercaptopurine IV on days 1-3, carmustine by continuous infusion on days 3-5, and streptozocin IV over 20 minutes on days 2-5. Patients receive treatment every 42 days, for up to 4 courses. Completion date provid...

Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
https://clinicaltrials.gov/ct2/show/NCT00214175

Feb 24th, 2012 - The primary objective is to evaluate and quantify the reproducibility of functional magnetic resonance imaging (fMRI) maps of the eloquent brain areas corresponding to specific neurological functions based on activation maps obtained with differen...

see more →

News  2 results

Cerebellar Large B-cell Lymphoma: A Case Report
https://www.staging.medscape.com/viewarticle/906321

Abstract and Introduction Abstract Background: Primary central nervous system lymphoma is a rare, malignant non-Hodgkin lymphoma that can arise in the brain, spinal cord, eye, leptomeninges, or cranial nerves. Primary central nervous system lympho...

Cerebellar Large B-cell Lymphoma: A Case Report
https://www.medscape.com/viewarticle/906321

Abstract and Introduction Abstract Background: Primary central nervous system lymphoma is a rare, malignant non-Hodgkin lymphoma that can arise in the brain, spinal cord, eye, leptomeninges, or cranial nerves. Primary central nervous system lympho...

see more →